News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Conference News ESC 2025 DAPT’s Role After CABG Questioned: TACSI and TOP-CABG Caitlin E. Cox September 05, 2025
News Conference News ESC 2025 NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure Michael O'Riordan September 04, 2025
News Conference News NY Valves 2025 Solid, Early Surgical Results With Polymer Mitral Valve Todd Neale July 02, 2025
News Daily News Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB Yael L. Maxwell June 14, 2024
News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023
News Daily News New AHA/ACC Performance and Quality Metrics for Coronary Revascularization Michael O'Riordan July 28, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
News Conference News ESC 2022 P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER Todd Neale August 29, 2022
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News SCAI 2021 Chinese Registry Supports Prolonged DAPT Following PCI for ACS Yael L. Maxwell May 03, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate L.A. McKeown February 26, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2020 Shelley Wood October 30, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2020 Shelley Wood July 31, 2020
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020